Home / Import refusals / AEK-9433073-3/10002/1

FDA Import Refusal AEK-9433073-3/10002/1 — CAPLIN POINT LTD

CAPLIN POINT LTD — FEI 3017551882

The FDA refused shipment AEK-9433073-3/10002/1 from CAPLIN POINT LTD (Guatemala) on February 20, 2026. The refused product falls under Drugs and Biologics — IBUPROFEN (ANTI-INFLAMMATORY). Cited charges: 118,75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
February 20, 2026
Country
Guatemala
Product Category
Drugs and Biologics
Product Code
62GCA41 IBUPROFEN (ANTI-INFLAMMATORY)
Charges
118,75

Other import refusals

  • 1FX-4666446-1/50002/1 (Wed Jul 01 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 1FX-4666446-1/60002/1 (Wed Jul 01 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 1FX-0135731-8/30002/2 (Fri Jun 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-9331533-9/20003/1 (Fri Mar 06 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-9331533-9/30003/1 (Fri Mar 06 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources